Terms: = Lymphoma AND RPL5, 6125, P46777, MSTP030, MGC117339, ENSG00000122406 AND Clinical Outcome
1 results:
1. Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens.
Maura F; Boyle EM; Coffey D; Maclachlan K; Gagler D; Diamond B; Ghamlouch H; Blaney P; Ziccheddu B; Cirrincione A; Chojnacka M; Wang Y; Siegel A; Hoffman JE; Kazandjian D; Hassoun H; Guzman E; Mailankody S; Shah UA; Tan C; Hultcrantz M; Scordo M; Shah GL; Landau H; Chung DJ; Giralt S; Zhang Y; Arbini A; Gao Q; Roshal M; Dogan A; Lesokhin AM; Davies FE; Usmani SZ; Korde N; Morgan GJ; Landgren O
Nat Cancer; 2023 Dec; 4(12):1660-1674. PubMed ID: 37945755
[TBL] [Abstract] [Full Text] [Related]
